rabies vaccine, human isolate
Vaccineapproved
Approved
Jul 1, 1942
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Apr 10, 2021 (NCT04852068)
Timeline
1940s
- Jul 1, 1942
Earliest FDA Approval
2020s
- Jan 1, 2021
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Lyssavirus rabiesImmunity, active
Lyssavirus rabies immunity, active
Approval history
- approvedJul 1, 1942
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rabies vaccine, human isolate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04852068 | Phase 3 | Apr 10, 2021 | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | For profit | 1 | 1 | 1 | 2021 |
1 organizations
Page 1 / 1